CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise President and CEO acquired 10,375 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 1,590 shares at $1.69 ($2,687)
- 4 Option exercise General Counsel acquired 2,688 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 15,000 shares at an average $1.18 ($17,646)
- 4 Open-market buy President and CEO bought 15,000 shares at an average $1.11 ($16,703)
- 4 Open-market buy President and CEO bought 15,000 shares at $2.01 ($30,224)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 6,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 200,000 shares at $2.25 ($450,000)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
Page 3 of 17 · 329 filings